Moderna Therapeutics
IPO News: Filed S-1: Moderna Files $500mm IPO
Moderna Therapeutics

Moderna

NASD:  MRNA

Initial Filing Date:  11/9/18

Size:  $500mm

Bookrunners:  Morgan Stanley | Goldman Sachs | J.P. Morgan

Major Holders:  Flagship Ventures Fund | AstraZeneca

Description:  Moderna is creating a new category of transformative medicines based on messenger RNA, or mRNA, to improve the lives of patients.

Reference Link:  S-1